Table 2.
Patients with exact genetic information, n (%) 525 (100%) 
Missense 239 (45.5%) 
Nonsense 80 (15.2%) 
Intronic 90 (17.1%) 
Deletion 76 (14.5%) 
Insertion 40 (7.6%) 
Classes of variants 525 (100%) 
Class I: missense in exon 1+2 or c.559+5G>A 209 (39.8%) 
Class II: other exact variants 316 (60.2%) 
Classification of variants according to ACMG criteria 525 (100%) 
Class I: missense in exon 1+2 or c.559+5G>A 209 (39.8%) 
Pathogenic 160 (76.6%) 
Likely pathogenic 37 (17.7%) 
VUS 11 (5.3%) 
Likely benign 1 (0.5%) 
Benign — 
Class II: other exact variants 316 (60.2%) 
Pathogenic 130 (41.1%) 
Likely pathogenic 133 (42.1%) 
VUS 49 (15.5%) 
Likely benign 1 (0.3%) 
Benign 3 (0.9%) 
Hot spots, n  
Class I  
c.C134T; p.Thr45Met 15 
p.Val75Met/Gly/Leu 60 
p.Arg86His/Leu/Gly/Cys 59 
c.559 +5 G>A 22 
Class II  
c.C121T ; p.Arg41X 10 
c.C631T; p.Arg211X 21 
c.777+1 G>A 10 
Patients with exact genetic information, n (%) 525 (100%) 
Missense 239 (45.5%) 
Nonsense 80 (15.2%) 
Intronic 90 (17.1%) 
Deletion 76 (14.5%) 
Insertion 40 (7.6%) 
Classes of variants 525 (100%) 
Class I: missense in exon 1+2 or c.559+5G>A 209 (39.8%) 
Class II: other exact variants 316 (60.2%) 
Classification of variants according to ACMG criteria 525 (100%) 
Class I: missense in exon 1+2 or c.559+5G>A 209 (39.8%) 
Pathogenic 160 (76.6%) 
Likely pathogenic 37 (17.7%) 
VUS 11 (5.3%) 
Likely benign 1 (0.5%) 
Benign — 
Class II: other exact variants 316 (60.2%) 
Pathogenic 130 (41.1%) 
Likely pathogenic 133 (42.1%) 
VUS 49 (15.5%) 
Likely benign 1 (0.3%) 
Benign 3 (0.9%) 
Hot spots, n  
Class I  
c.C134T; p.Thr45Met 15 
p.Val75Met/Gly/Leu 60 
p.Arg86His/Leu/Gly/Cys 59 
c.559 +5 G>A 22 
Class II  
c.C121T ; p.Arg41X 10 
c.C631T; p.Arg211X 21 
c.777+1 G>A 10 

Defined as ≥10 patients with this variant.

or Create an Account

Close Modal
Close Modal